H. Bijie

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

M. Pfaller, D. Diekema, V. Letscher-Bru, 2007, Journal of Clinical Microbiology.

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

M. Mallié, R. Barton, Shan-Chwen Chang, 2010, Diagnostic microbiology and infectious disease.

In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.

A. Soebandrio, H. Bijie, S. Kulpradist, 2005, Journal of chemotherapy.

International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009.

A. Gikas, A. Barkat, D. Maki, 2010, American journal of infection control.

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009.

Y. Mehta, A. Gikas, D. Fisher, 2012, American journal of infection control.

Targeted surveillance of catheter-related infections in ICU of 65 hospitals in Shanghai during 2009-2010

H. Bijie, Gao Xiaodong, Zhou Qing, 2011 .

Clinical features of and diagnostic approaches for abdominal tuberculosis: 5-year experience from a non-tuberculosis-designated hospital in China.

H. Bijie, Qingqing Wang, Jin Wenting, 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.